Healthcare >> CEO Interviews >> April 12, 2013

Interview with the Founder, Chairman, President and CEO: Dyadic International (DYAI)

Emalfarb, Mark A.
Mark A. Emalfarb is the Founder of Dyadic International. He has been a member of Dyadicís board of directors since October 2004, and he has served as its Chairman, President and Chief Executive Officer from October 2004 until April 2007, and from June 2008 until the present. Since founding Dyadic in 1979, Mr. Emalfarb has successfully led and managed the evolution of Dyadic from its origins as a pioneer and leader in providing ingredients used in the stone washing of blue jeans to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of an integrated technology platform based on Dyadicís patented and proprietary C1 fungal microorganism. Mr. Emalfarb is an inventor of more than 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to the companyís patented and proprietary C1 fungus. He has been the architect behind its formation of several strategic research and development, manufacturing and marketing relationships with U.S. and international partners. Mr. Emalfarb earned his B.A. degree from the University of Iowa in 1977. Profile
TWST: Please begin with a short introduction to Dyadic International.

Mr. Emalfarb: Dyadic International is a biotechnology company that operates around the globe, that has developed a